Top Story

Male pattern baldness increased risk for aggressive prostate cancer

October 17, 2014

Men who exhibited frontal plus moderate vertex baldness by age 45 years were at increased risk for developing aggressive prostate cancer, according to study findings.

“Male pattern baldness seems to share pathologic mechanisms with prostate cancer in terms of advancing age, hereditability, and endogenous hormones,” the researchers wrote. “The fact that the age of observable hair loss coincides with the age of microscopic evidence for prostate cancer in autopsy studies, and that male pattern baldness represents cumulative exposures, as opposed to a single serum measurement, may help elucidate prostate cancer etiology.”

figure In the Journals

One-third of cancer patients experienced anxiety, mental health disorders

October 6, 2014
About one in three patients with cancer experienced some level of clinically relevant mental health challenge, such as anxiety, depressive disorders or adjustment…
In the Journals

Increased prostate, pancreatic cancer risks among BRCA mutation carriers support additional screening

October 3, 2014
Individuals with BRCA2 mutations demonstrated significantly higher risks for pancreatic cancer and prostate cancer than noncarriers, according to study results.The…
figure Meeting News Coverage

Watchful waiting may not benefit black men with low-grade prostate cancer

October 3, 2014
In patients with low-grade prostate cancer, black race was associated with poorer outcomes in terms of freedom from biochemical failure after radical prostatectomy…
CME
figure

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
figure

Docetaxel plus ADT improved OS in metastatic prostate cancer

June 24, 2014
CHICAGO — Donald L. Trump, MD, FACP, president and CEO at Roswell Park Cancer Institute and HemOnc Today
More »
CME
figure

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »

Filter By:

figure In the Journals

Male pattern baldness increased risk for aggressive prostate cancer

October 17, 2014
Men who exhibited frontal plus moderate vertex baldness by age 45 years were at increased risk for developing aggressive prostate cancer, according…
figure In the Journals

One-third of cancer patients experienced anxiety, mental health disorders

October 6, 2014
About one in three patients with cancer experienced some level of clinically relevant mental health challenge, such as anxiety, depressive disorders…
In the Journals

Increased prostate, pancreatic cancer risks among BRCA mutation carriers support additional screening

October 3, 2014
Individuals with BRCA2 mutations demonstrated significantly higher risks for pancreatic cancer and prostate cancer than noncarriers, according to…
figure Meeting News Coverage

Watchful waiting may not benefit black men with low-grade prostate cancer

October 3, 2014
In patients with low-grade prostate cancer, black race was associated with poorer outcomes in terms of freedom from biochemical failure after radical…
figure In the Journals

Less disease education linked to greater decisional conflict in prostate cancer

October 1, 2014
Patients with less knowledge about prostate cancer are more likely to have decisional conflict and have less confidence in their decision-making…
Meeting News Coverage

Aspirin, NSAIDs reduced risk for aggressive prostate cancer

September 29, 2014
Men with elevated PSA and a negative prostate biopsy who used aspirin and/or other NSAIDs demonstrated a significantly reduced risk for aggressive…
figure Meeting News Coverage Perspective

Shorter ADT regimen improved quality of life among men with high-risk prostate cancer

September 16, 2014
Men with high-risk prostate cancer who underwent treatment with radiotherapy plus 18 months of androgen deprivation therapy demonstrated improved…
figure

Report: Commitment to NIH, NCI funding only 'viable path' for continued success in cancer research

September 16, 2014
The scientific community’s continued quest to prevent and cure cancer has reached a crossroads, according to a report released today by the…
In the Journals

AR-V7 linked to treatment resistance in castration-resistant prostate cancer

September 16, 2014
Detectable androgen receptor splice variant-7 messenger RNA in circulating tumor cells was associated with resistance to enzalutamide and abiraterone…
Meeting News Coverage Perspective

High-dose radiation plus long-term ADT extended survival in prostate cancer

September 15, 2014
Men with intermediate or high-risk prostate cancer who underwent high-dose radiation therapy followed by a longer duration of androgen deprivation…
More Headlines »